← Leaderboards
Mauricio Rojas
Vanderbilt University
$8,371,478
Attributed
$11,467,594
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,467,594 · 11
By mechanism
U54$3,382,057 · 2
R01$3,329,548 · 2
U01$2,354,168 · 1
R42$968,298 · 1
P50$733,045 · 1
K01$649,792 · 1
Top collaborators
- Ana L Mora8 shared
- Panagiotis V Benos4 shared
- Toren Finkel4 shared
- Robert A Lafyatis4 shared
- Anthony Ting3 shared
- Maria M. Mihaylova1 shared
- Alison Morris1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard N Pierson$28,134,227
- Richard M Caprioli$30,630,395
- Constantin F Aliferis$3,148,379
- Erin J Plosa$3,440,910
- Yu Shyr$30,935,638
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungCellsBaseTissuesResponseBiologicalStem CellsOrganMesenchymal Stem CellsBone MarrowAgingAnimalsRepairedPathologyResearch PersonnelLung DiseasesUniversitiesPathogenesisInjuryResourcesPulmonary FibrosisInflammationProgramsAnimal Model
Grant awards (32)
Regulation of Repair Responses in the Lung by Fatty Acid Oxidation$696,377
R01 · FY2025 · HL
Biospecimen-Core$658,170
U54 · FY2025 · AG · contact PI
Regulation of Repair Responses in the Lung by Fatty Acid Oxidation$693,306
R01 · FY2024 · HL
Biospecimen-Core$658,170
U54 · FY2024 · AG · contact PI
5th Annual MAC (Midwest Aging Consortium) Aging Research Symposium$25,000
R13 · FY2024 · AG · contact PI
Biospecimen-Core$658,170
U54 · FY2023 · AG · contact PI
Biospecimen-Core$656,950
U54 · FY2022 · AG · contact PI
Mapping Age-Related Changes in the Lung$543,214
U01 · FY2022 · HL · contact PI
Biospecimen-Core$750,597
U54 · FY2021 · AG · contact PI
Mapping Age-Related Changes in the Lung$558,954
U01 · FY2021 · HL · contact PI
Core 2: Lung Tissue Core$138,701
P50 · FY2021 · AR · contact PI
Mapping Age-Related Changes in the Lung$626,000
U01 · FY2020 · HL · contact PI
Core 2: Lung Tissue Core$138,701
P50 · FY2020 · AR · contact PI
Mapping Age-Related Changes in the Lung$626,000
U01 · FY2019 · HL · contact PI
Core 2: Lung Tissue Core$138,701
P50 · FY2019 · AR · contact PI
Aging of Mesenchymal Stem Cells Missing Link in IPF$477,234
R01 · FY2018 · HL · contact PI
Core 2: Lung Tissue Core$129,895
P50 · FY2018 · AR · contact PI
Aging of Mesenchymal Stem Cells Missing Link in IPF$475,275
R01 · FY2017 · HL · contact PI
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$293,537
R42 · FY2017 · AA
Core 2: Lung Tissue Core$187,047
P50 · FY2017 · AR · contact PI
Aging of Mesenchymal Stem Cells Missing Link in IPF$484,669
R01 · FY2016 · HL · contact PI
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$450,040
R42 · FY2016 · AA
Aging of Mesenchymal Stem Cells Missing Link in IPF$502,687
R01 · FY2015 · HL · contact PI
Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome$224,721
R42 · FY2014 · AA
Aging and Lung Disease: Clinical Impact and Cellular and Molecular Pathways$25,686
R13 · FY2014 · HL · contact PI
Repair Mechanisms of Adult Mesenchymal Stem Cells in Lung Injury$133,413
K01 · FY2011 · HL · contact PI
Repair Mechanisms of Adult Mesenchymal Stem Cells in Lung Injury$133,413
K01 · FY2010 · HL · contact PI
Repair Mechanisms of Adult Mesenchymal Stem Cells in Lung Injury$130,485
K01 · FY2009 · HL · contact PI
Repair Mechanisms of Adult Mesenchymal Stem Cells in Lung Injury$127,627
K01 · FY2008 · HL · contact PI
Repair Mechanisms of Adult Mesenchymal Stem Cells in Lung Injury$124,854
K01 · FY2007 · HL · contact PI
Targeting signal transduction pathways in autoimmunity$0
P30 · FY2002 · AR
Targeting signal transduction pathways in autoimmunity$0
P30 · FY2001 · AR